deaths (OS)progression or deaths (PFS)RFS/DFS

mNSCLC - L1 - all population metastatic/advanced NSCLC (mNSCLC) - 1st line (L1) mNSCLC - L1 - all population

versus Standard of Care (SoC)
durvalumab alone vs. Standard of Care (SoC) 1 -551 [-1153; 51] /10000
278/374 vs. 297/372
--